Literature DB >> 8721694

Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries.

E Mangieri1, G Macchiarelli, M Ciavolella, F Barillà, A Avella, A Martinotti, L J Dell'Italia, G Scibilia, P Motta, P P Campa.   

Abstract

Slow flow of dye in epicardial coronary arteries is not an infrequent finding in patients during routine coronary angiography. Whether this pattern of flow can be reversed by nitroglycerin or dipyridamole and whether this angiographic finding is associated with histopathological abnormalities is unknown. We hypothesized that this abnormality could be associated with small vessel disease of the heart, since the epicardial arteries are usually widely patent. Thus, out of the patients undergoing heart catheterization at our institution during the past 5 years, 10 (7%) presented with chest pain, normal epicardial coronary arteries, and abnormal coronary progression of dye. Rest electrocardiogram (ECG), exercise test, echocardiographic examination, and left ventricular angiogram were normal. Coronary angiography showed slow flow of dye on a total of 20 main coronary vessels, that was not reversed by intracoronary nitroglycerin administration. Six of them underwent dipyridamole intravenous infusion that normalized dye run-off in all affected vessels, for a total of 9 main coronary vessels. Histopathological examination (light and electron microscope) of left ventricular endomyocardial biopsies showed thickening of vessel walls with luminal size reduction, mitochondrial abnormalities, and glycogen content reduction. Normal and pathological zones often coexisted in the same specimen. Thus. In some patients with slow coronary flow and patent coronary arteries, functional obstruction of microvessels seems to be implicated, as it is relieved by dipyridamole infusion. Patchy histopathological abnormalities suggestive of small vessel disease are also detectable and could contribute to increase flow resistance.

Entities:  

Mesh:

Year:  1996        PMID: 8721694     DOI: 10.1002/(SICI)1097-0304(199604)37:4<375::AID-CCD7>3.0.CO;2-8

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  67 in total

Review 1.  The coronary slow flow phenomenon: characteristics, mechanisms and implications.

Authors:  Xiao Wang; Shao-Ping Nie
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

2.  Relationship between serum visfatin levels and coronary slow-flow phenomenon.

Authors:  Huseyin Altug Cakmak; Serkan Aslan; Ahmet Arif Yalcin; Ibrahim Faruk Akturk; Burce Yalcin; Fatih Uzun; Derya Ozturk; Mehmet Erturk; Mehmet Gul
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

3.  Predictive Value of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Patients with Coronary Slow Flow.

Authors:  Mustafa Çetin; Emrullah Kiziltunc; Özgül Uçar Elalmış; Zehra Güven Çetin; Muhammed Bora Demirçelik; Hülya Çiçekçioğlu; Alparslan Kurtul; Selçuk Özkan; Candan Mansuroğlu Avan; Ender Örnek; Feridun Vasfi Ulusoy
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

4.  Recurrence of Takotsubo cardiomyopathy with coronary slow flow phenomenon.

Authors:  Tomotake Tokunou; Kenji Sadamatsu
Journal:  J Cardiol Cases       Date:  2012-03-16

5.  Are biventricular systolic functions impaired in patient with coronoray slow flow? A prospective study with three dimensional speckle tracking.

Authors:  Tuğba Kemaloğlu Öz; Mehmet Eren; Işıl Atasoy; Tayfun Gürol; Özer Soylu; Bahadır Dağdeviren
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-06       Impact factor: 2.357

6.  Coronary Slow Flow Phenomenon Leads to ST Elevation Myocardial Infarction.

Authors:  Taner Sen
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

7.  Effects of nebivolol on endothelial function and exercise parameters in patients with slow coronary flow.

Authors:  Selma Tiryakioglu; Osman Tiryakioglu; Hasan Ari; Mehmet C Basel; Tahsin Bozat
Journal:  Clin Med Cardiol       Date:  2009-11-03

8.  Increased platelet activation in patients with slow coronary flow.

Authors:  Turgay Celik; U Cagdas Yuksel; Baris Bugan; Atila Iyisoy; Murat Celik; Sait Demirkol; Halil Yaman; Hurkan Kursaklioglu; Selim Kilic; Ersoy Isik
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

9.  Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism.

Authors:  Halil Tanriverdi; Harun Evrengul; Hatice Mergen; Ceren Acar; Deniz Seleci; Omur Kuru; Seyhan Tanriverdi; Asuman Kaftan
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

10.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.